CRON
Cronos Group Inc
NASDAQ: CRON · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$2.58
-2.64% today
Updated 2026-04-29
Market cap
$1.02B
P/E ratio
—
P/S ratio
6.93x
EPS (TTM)
$-0.02
Dividend yield
—
52W range
$2 – $3
Volume
1.5M
Cronos Group Inc (CRON) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $-195611.00 | $-665000.00 | $3.40M | $412322.00 | $3.25M | $12.12M | $23.75M | $46.72M | $64.56M | $86.75M | $87.24M | $117.61M | $193.36M |
| Revenue growth (YoY) | — | -240.0% | +612.0% | -87.9% | +687.2% | +273.4% | +95.9% | +96.7% | +38.2% | +34.4% | +0.6% | +34.8% | +64.4% |
| Cost of revenue | — | $32164.00 | $144981.00 | $-1.07M | $1.98M | $5.91M | $41.35M | $72.55M | $82.15M | $71.31M | $75.33M | $92.42M | $130.60M |
| Gross profit | $-195611.00 | $-32164.00 | $2.50M | $1.48M | $1.27M | $6.21M | $-17.60M | $-25.83M | $-17.59M | $15.44M | $11.91M | $25.20M | $62.76M |
| Gross margin | 100.0% | 4.8% | 73.6% | 359.7% | 39.1% | 51.3% | -74.1% | -55.3% | -27.3% | 17.8% | 13.7% | 21.4% | 32.5% |
| R&D | — | $0.00 | $2.35M | $2.35M | $2.35M | $1.73M | $12.15M | $20.37M | $21.84M | $13.13M | $5.84M | $4.23M | $4.45M |
| SG&A | $423506.00 | $2.02M | $1.61M | $2.78M | $7.00M | $21.50M | $93.10M | $95.93M | $100.76M | $82.68M | $58.23M | $55.21M | $42.00M |
| Operating income | $-619475.00 | $-3.04M | $540336.00 | $-1.23M | $-6.12M | $-20.45M | $-153.32M | $-219.39M | $-291.97M | $-111.43M | $-84.80M | $-76.53M | $-2.93M |
| Operating margin | 316.7% | 457.7% | 15.9% | -297.1% | -188.6% | -168.7% | -645.5% | -469.6% | -452.2% | -128.4% | -97.2% | -65.1% | -1.5% |
| EBITDA | $-619475.00 | $-3.25M | $559960.00 | $-851000.00 | $-5.35M | $-18.85M | $1.17B | $-66.04M | $-150.13M | $-91.27M | $-71.80M | $-50.21M | $-15.00M |
| EBITDA margin | 316.7% | 489.0% | 16.4% | -206.4% | -164.9% | -155.5% | 4932.4% | -141.4% | -232.5% | -105.2% | -82.3% | -42.7% | -7.8% |
| EBIT | $-619475.00 | $-3.28M | $478299.00 | $-1.14M | $-6.15M | $-20.78M | $1.17B | $-73.09M | $-165.53M | $-104.39M | $-79.91M | $-59.55M | $-17.12M |
| Interest expense | $0.00 | $1.10M | $325170.00 | $177274.00 | $100198.00 | $78559.00 | $32.96M | $186000.00 | $27000.00 | $13000.00 | — | — | — |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-619475.00 | $-4.15M | $278279.00 | $-885000.00 | $-1.48M | $-21.64M | $1.17B | $-73.14M | $-396.11M | $-168.73M | $-73.96M | $41.08M | $-9.45M |
| Net income growth (YoY) | — | -570.1% | +106.7% | -418.0% | -67.6% | -1358.9% | +5491.5% | -106.3% | -441.6% | +57.4% | +56.2% | +155.5% | -123.0% |
| Profit margin | 316.7% | 624.2% | 8.2% | -214.6% | -45.7% | -178.5% | 4911.6% | -156.5% | -613.5% | -194.5% | -84.8% | 34.9% | -4.9% |